WORLD’S LARGEST STUDY IN INTRAVENOUS CATHETER SECUREMENT FOR CHILDREN AND CATHETER FAILURE REDUCTION
Brooke Charters, Paediatric Emergency Nurse
Gold Coast Hospital and Health Service
PEOPLE IN HEALTH CARE
Filmed in Southport, Queensland | December 2024
Brooke Charters is a dynamic Paediatric Emergency Nurse who works at the Gold Coast University Hospital in Queensland.
After leaving school unsure of her career path, she ventured into disability support, which sparked her interest in nursing. She pursued a Bachelor of Nursing at Southern Cross University, and during her placement in Africa, she discovered her passion for paediatrics instead of mental health nursing.
Since completing her post grad certificate in paediatric acute care and a passion ignited from working frontline in the Paediatric Emergency, Brooke has developed a wide variety of clinical research interests, especially in cannulation, children’s mental health trauma and pain management.
An opportunity arose when she was approached for research ideas related to securing cannulas, a frequent issue in paediatric care.
Brooke was the first nurse to become a Principal Investigator on an Emergency Medicine Foundation (EMF) Queensland Research Program grant when it was opened to nurses. Having seen first-hand how one in four cannulas used in treating children were failing
and needed to be reinserted Brooke looked for an opportunity to find a solution.
The study enrolled children aged six months to eight years, aiming to save cannulas and reduce reinsertion trauma. Her study’s findings showed significant improvements in securing cannulas, highlighting a potential solution to a common problem.
Brooke initiated a study with a randomised control trial (RCT) comparing standard care to an integrated dressing with tissue adhesive.
Brooke’s research became the world’s largest study of its kind and in May 2024 the results of the study were published in JAMA Pediatrics. Her mission is to drive change and enhance the hospital experience for children globally.
-
Updated handbook on chronic kidney disease management in primary care
Kidney Health Australia’s latest kidney disease guide for primary care practitioners is expected to be pivotal in slowing down the rates of kidney failure, which have doubled in the past 20 years and if left unchecked will grow by a further 42% by 2030, according to the health charity.
With specific reference to new kidney treatments and culturally safe kidney care for First Nations Australians, the 5th edition of Chronic Kidney Disease (CKD) Management in Primary Care handbook, known as the ‘kidney bible’, is a significant step-up in enabling earlier diagnosis of kidney disease for GPs and other front-line healthcare professionals.
-
Smart technology in wound care
Throughout her journey around wound care, Santosh Kaur was frustrated to see the simple gaps in wound care resulting in negative patient outcomes. Santosh is the founder of SmartHeal which launched in 2020.
SmartHeal replaces the nurses taking cumbersome manual measurements and manual sharing of important wound data with a no touch technique. It aims for healthcare professionals to have live remote access to wound data, make wound assessments and assist with speech to text notes thus saving time, cost and people. SmartHeal also aims to assist healthcare professionals in providing optimum wound care by analysing the wound tissue for infection, moisture and providing suggestions for suitable dressing.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.
